NDC 65841-603

Ribavirin

Ribavirin

Ribavirin is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Cadila Healthcare Limited. The primary component is Ribavirin.

Product ID65841-603_1596fe48-b374-4c0c-b2ae-1ceb802ca2ba
NDC65841-603
Product TypeHuman Prescription Drug
Proprietary NameRibavirin
Generic NameRibavirin
Dosage FormTablet, Film Coated
Route of AdministrationORAL
Marketing Start Date2005-12-05
Marketing CategoryANDA / ANDA
Application NumberANDA077094
Labeler NameCadila Healthcare Limited
Substance NameRIBAVIRIN
Active Ingredient Strength400 mg/1
Pharm ClassesNucleoside Analog [EXT],Nucleoside Analog Antiviral [EPC]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 65841-603-07

56 TABLET, FILM COATED in 1 BOTTLE (65841-603-07)
Marketing Start Date2005-12-05
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 65841-603-07 [65841060307]

Ribavirin TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA077094
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2005-12-05

NDC 65841-603-17 [65841060317]

Ribavirin TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA077094
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2005-12-05

NDC 65841-603-14 [65841060314]

Ribavirin TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA077094
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2005-12-05

Drug Details

Active Ingredients

IngredientStrength
RIBAVIRIN400 mg/1

OpenFDA Data

SPL SET ID:666e8b22-f519-460b-a774-88a621d56139
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 597722
  • 248109
  • 597718
  • 790286
    • UPC Code
  • 0365841129076

    • Pharmacological Class

    • Nucleoside Analog [EXT]
    • Nucleoside Analog Antiviral [EPC]

    NDC Crossover Matching brand name "Ribavirin" or generic name "Ribavirin"

    NDCBrand NameGeneric Name
    0781-2043RibavirinRibavirin
    0781-5177RibavirinRibavirin
    42494-423RibavirinRibavirin
    53808-0781RibavirinRIBAVIRIN
    53808-0782RibavirinRIBAVIRIN
    54738-950ribavirinribavirin
    54738-951ribavirinribavirin
    54738-952ribavirinribavirin
    54738-953ribavirinribavirin
    63629-2149RibavirinRibavirin
    65841-046RibavirinRibavirin
    65841-129RibavirinRibavirin
    65841-260RibavirinRibavirin
    65841-603RibavirinRibavirin
    65841-632RibavirinRibavirin
    65862-207RibavirinRibavirin
    68084-179RibavirinRibavirin
    68382-046RibavirinRibavirin
    68382-260RibavirinRibavirin
    68382-129RibavirinRibavirin
    68382-128RibavirinRibavirin
    68382-395RIBAVIRINRIBAVIRIN
    68382-127RibavirinRibavirin
    68682-019RibavirinRibavirin
    65862-290RibavirinRibavirin
    68475-003RIBAVIRINRIBAVIRIN
    0074-3197ModeribaRibavirin
    0074-3282ModeribaRibavirin
    0085-1318REBETOLribavirin
    0187-0007VirazoleRibavirin
    © 2025 FDA.report
    This site is not affiliated with or endorsed by the FDA.